Patents Assigned to B3AR THERAPEUTICS, INC.
  • SOLABEGRON ZWITTERION AND USES THEREOF
    Publication number: 20240124391
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: May 18, 2023
    Publication date: April 18, 2024
    Applicant: B3AR THERAPEUTICS, INC.
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE
  • Solabegron zwitterion and uses thereof
    Patent number: 11691944
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: July 4, 2023
    Assignee: B3AR THERAPEUTICS, INC.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele